AbbVie Inc. (ABBV) |
|
80.02 1.27 (1.61%)
|
02-22 16:00 |
|
Open: |
79.16 |
Pre. Close: |
78.75 |
|
High:
|
80.19 |
Low:
|
78.2437 |
|
Volume:
|
5,022,750 |
Market Cap:
|
120368M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
80.228 - 80.712 |
80.712 - 81.176 |
|
Low:
|
77.1 - 77.667 |
77.667 - 78.211 |
|
Close:
|
79.13 - 79.976 |
79.976 - 80.786 |
|
|
|
Technical analysis |
as of: 2019-02-22 4:39:32 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 98.62 One year: 104.87 |
| Support: |
Support1: 75.77 Support2: 63.04 |
| Resistance: |
Resistance1: 84.43 Resistance2: 89.79 |
| Pivot: |
79.85  |
| Moving Average: |
MA(5): 80.02 MA(20): 79.61
MA(100): 86.33 MA(250): 93.69 |
| MACD: |
MACD(12,26): -1.33 Signal(9): -1.59 |
| Stochastic oscillator: |
%K(14,3): 50.92 %D(3): 61.73 |
| RSI: |
RSI(14): 43.96 |
| 52-week: |
High: 122.00 Low: 75.77 Change(%): -32.6 |
| Average Vol(K): |
3-Month: 706509 10-Days: 519287 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.ABBV has closed below upper band by 44.3%. Bollinger Bands are 74.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to ABBV's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Fri, 22 Feb 2019 20:11:31 Z
Why Voyager Therapeutics Is Skyrocketing Today
Fri, 22 Feb 2019 17:47:23 Z
Energy Sector Update for 02/22/2019: VYGR, ABBV
Fri, 22 Feb 2019 05:09:46 Z
What Pharma Investors Need to Know About Pfizer's Latest Disaster
Wed, 20 Feb 2019 19:07:04 Z
AbbVie's RA Candidate Upadacitinib Gets FDA Priority Review
Wed, 20 Feb 2019 17:09:40 Z
Notable ETF Outflow Detected - IYH, ABT, MDT, ABBV
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Major |
| Shares Out. (M) |
1504.22 |
| Shares Float (M) |
1502.96 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
112.00 |
|
Shares Short (K)
|
25313 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
7.910 |
|
EPS Est. Current Year
|
5.530 |
|
EPS Est. Next Year
|
6.560 |
|
EPS Est. Next Quarter
|
1.440 |
|
Forward EPS
|
8.888 |
|
Book Value (p.s.)
|
39.310 |
|
PEG Ratio
|
0.97 |
|
Profit Margin
|
16.99 |
|
Operating Margin
|
37.34 |
|
Return on Assets (ttm)
|
8.4 |
|
Return on Equity (ttm)
|
116.6 |
|
Qtrly Rev. Growth
|
7.3 |
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
P/E
|
10.12 |
|
P/E Growth Ratio
|
0.02 |
|
P/BV
|
2.04 |
|
P/S
|
5663756288.00 |
|
P/CF
|
|
Dividends & Splits |
|
Dividend
|
5.294 |
|
Dividend Yield
|
0.07 |
|
Dividend Pay Date
|
2019-02-15 |
|
Ex-Dividend Date
|
2019-01-14 |
|
Forward Dividend
|
4.280 |
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
